PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32876513-7	2021	The IGF2BP1-SRC/ERK2 axis is targetable by the SRC-inhibitor saracatinib and MEK-inhibitor selumetinib.	AZD 6244	91-102	insulin-like growth factor 2 mRNA binding protein 1	Mus musculus	4-11